Identifying Neuroinflammatory Signals Through Multiplex Analysis
We’re proud to showcase groundbreaking research from our valued customers at the Hudson Institute of Medical Research and Monash University, presented at last year at ASSCR 2025.
Why we found this exciting:
Their latest research investigates the use of genetically engineered induced pluripotent stem cell-derived neural stem cells (iPSC-NSCs) as a potential therapy for ischaemic stroke, an area where effective neuroregenerative treatments remain urgently needed.
How Luminex MAGPIX Multiplexing Platform supported the research:
A key component of their research workflow was the Luminex® MAGPIX® multiplexing platform, which enabled rapid and sensitive measurement of inflammatory biomarkers within their stroke model. Using MAGPIX®, the team identified a significant elevation of MIP-1α (CCL3) just 24 hours following stroke onset, providing valuable insights into the brain’s inflammatory response and highlighting the therapeutic potential of engineered neural stem cells.
We’re honoured to support scientists who are pushing the boundaries of regenerative medicine and improving our understanding of neurological disease.
Congratulations to Sandra Li, Chuanyu Wei, Justin Moore, Connie Wong and Courtney McDonald!
